Cargando…
Apolipoprotein C-III and cardiovascular diseases: when genetics meet molecular pathologies
Cardiovascular diseases (CVD) have overtaken infectious diseases and are currently the world’s top killer. A quite strong linkage between this type of ailments and elevated plasma levels of triglycerides (TG) has been always noticed. Notably, this risk factor is mired in deep confusion, since its ro...
Autores principales: | Dib, Israa, Khalil, Alia, Chouaib, Racha, El-Makhour, Yolla, Noureddine, Hiba |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778846/ https://www.ncbi.nlm.nih.gov/pubmed/33389539 http://dx.doi.org/10.1007/s11033-020-06071-5 |
Ejemplares similares
-
The evolution of nucleosidic analogues: self-assembly of prodrugs into nanoparticles for cancer drug delivery
por: Baroud, Milad, et al.
Publicado: (2021) -
Azacitidine Omega-3 Self-Assemblies: Synthesis, Characterization, and Potent Applications for Myelodysplastic Syndromes
por: Baroud, Milad, et al.
Publicado: (2021) -
Cardiovascular Disease Risk in Children With Chronic Kidney Disease: Impact of Apolipoprotein C-II and Apolipoprotein C-III
por: Chen, Wei-Ling, et al.
Publicado: (2021) -
Apolipoprotein C-III reduction in subjects with moderate hypertriglyceridaemia and at high cardiovascular risk
por: Tardif, Jean-Claude, et al.
Publicado: (2022) -
When diet meets genetics
por: Chella Krishnan, Karthickeyan
Publicado: (2023)